NORTH
CHICAGO, Ill., Sept. 6,
2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will
participate in the Morgan Stanley 21st Annual Global Healthcare
Conference on Wednesday, September 13,
2023. Robert A. Michael,
president and chief operating officer, Scott Reents, executive vice president, chief
financial officer, Jeffrey R.
Stewart, executive vice president, chief commercial officer
and Roopal Thakkar, senior vice
president, development and regulatory affairs and chief medical
officer, will present at 9:50 a.m. Central
time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
and solutions that solve serious health issues today and address
the medical challenges of tomorrow. We strive to have a remarkable
impact on people's lives across several key therapeutic areas –
immunology, oncology, neuroscience, and eye care – and products and
services in our Allergan Aesthetics portfolio. For more information
about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on
Twitter, Facebook, Instagram, YouTube and LinkedIn.
View original
content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-morgan-stanley-healthcare-conference-301914307.html
SOURCE AbbVie